Tata Steel Trials Canadian Iron Ore for Future Shortages
Tata Steel books first bulk shipment from Canada to hedge against captive mine expiries in 2030. A strategic move to secure raw material supply and explore future options. Read more.
Category : Search result: Nifty expiry week
Meesho shares fall 5% post lock-in expiry, brokers positive
Meesho's shares fell 5% after a lock-in period ended, releasing 110 million shares. Major brokerages like UBS remain optimistic, citing strong growth potential in India's mass market. Read the full analysis.
Meesho stock falls 5% after IPO lock-in expiry
Meesho shares fell 5% as a 1-month lock-in for pre-IPO investors ended, making 109.9 million shares eligible for trade. Analysts cite increased supply and high valuations for the pressure.
$45B IPO Lock-In Expiry for 96 Firms Jan-Apr
A massive $45 billion worth of IPO lock-in periods are set to expire for 96 Indian companies between Jan 6 and Apr 30. Learn which stocks are affected and how it could impact prices.
$45 Billion IPO Lock-In Expiry May Trigger Volatility
A massive $45 billion worth of IPO lock-in expiries are set to hit Indian markets in coming months, potentially triggering volatility. Nuvama warns of pressure on specific stocks. Read the full analysis.
Market Falls for 2nd Day; 5 Breakout Stocks to Buy Now
Indian stock markets continued their decline on Tuesday. Despite a partial recovery, Sensex and Nifty closed lower. Expert Sumeet Bagadia shares technical outlook and 5 breakout stock picks for today.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Canada's Undocumented Immigrant Crisis: 2 Million by 2026
Canada faces a surge in undocumented immigrants as work permits expire. With nearly half from India, expert Kanwar Seirah warns of social impact. Learn the critical details.
Tesla Loses Top EV Spot to BYD After 2025 Sales Decline
Tesla's global EV crown slips to China's BYD after a 9% delivery drop in 2025. Intense competition and expiring US tax credits hit sales. Can Musk's robotaxi and robotics pivot revive fortunes? Read the full analysis.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
5 Indian Sectors Beat Nifty in Volatile 2025 Market
Despite a tough 2025 for Indian equities, five sectors soared: PSU Banks, Metals, Auto, Defence, and Private Banks. Discover the drivers behind their stellar performance and what it means for investors.
42 kg Undated Bread Seized from Noida Fast Food Outlet
Food safety officials in Noida seized over 42 kg of Italian bread lacking expiry dates from a major sandwich chain. The crackdown is part of pre-New Year inspections across GB Nagar. Read for details.
Market Cautious on F&O Expiry, Gold & Bitcoin Correct
Indian stock markets consolidate amid F&O expiry and profit booking. Gold prices correct sharply by ₹5,000, Bitcoin slips ₹55,000. Experts share Nifty, Bank Nifty outlook and 8 stock picks for today.
Indian Markets Eye Flat, Negative Open on December 30
Indian stock markets are poised for a flat to negative opening on Tuesday, December 30, 2025, following weak global signals. Get the latest on Sensex, Nifty outlook, and expert stock picks.
Indian Markets to Consolidate in Final 2025 Trading Sessions
Indian stock markets are set to end 2025 with double-digit gains despite a tough year. With two sessions left, experts predict consolidation and advise selective, value-focused investing for 2026.
Indian Markets Eye 5th Consecutive Drop on Dec 30
Sensex and Nifty 50 are poised for a negative start, extending losses amid global cues and FII selling. Get expert technical analysis and key support-resistance levels for today's trade.
Nifty, Sensex Flat in Thin Trade; Expiry May Spike Volatility
Indian equity benchmarks opened flat on Thursday with low volumes as the year draws to a close. Analysts warn of potential volatility due to the monthly F&O expiry. Key sectors and stocks in focus.
Markets Cautious Ahead of 2025 Year-End Derivatives Expiry
Indian stock markets brace for a cautious final week of 2025 as FPIs and prop traders build significant bearish positions. Nifty expected to trade sideways with a bearish bias amid thin holiday volumes. Key details inside.
Kajol's evolving views on marriage and roles
Kajol's journey from rejecting marital stereotypes to proposing expiry dates reflects a common evolution. A psychologist explains why our ideas of an ideal marriage change over time.
Market Outlook: Expiry, Year-End to Cap Gains, Says Bhambwani
Vijay L. Bhambwani's analysis suggests monthly expiry and low year-end participation could restrict market upside. PSU banks and metals may see action, while bullion volatility persists. Trade light with stops.
Market Eyes Economic Data, F&O Expiry in Final 2025 Stretch
Indian stock markets enter the year's final stretch with a focus on key economic data, auto sales, and global cues. Analysts expect range-bound trading with heightened volatility. Read more.
SC: No Grace Period for Expired Driving Licence
The Supreme Court has ruled that a driving licence is not valid after its expiry date unless renewed. Learn the legal implications and renewal process to avoid penalties.
Nifty 50 Target 30,000 by 2026: Report
A new report predicts the Nifty 50 index could surge to 30,000 by 2026, driven by a bull market correction and strong technical indicators. Discover the key factors and sectoral bets for this projected growth.
Hurricanes' Jaccob Slavin Injured, Out Week-to-Week
Carolina Hurricanes defenseman Jaccob Slavin is out week-to-week with an upper-body injury, a major blow to the team's defense. Get the latest update on his status and its impact.
Stock Market Outlook: Flat Start, Nifty Target 26,450
Indian markets may open flat to positive amid stable global cues. GIFT Nifty hints at calm start. Expert Vaishali Parekh sees Nifty heading to 26,450, shares 3 intraday stock picks. Read for key levels and strategy.
Stock Market Today: Sensex, Nifty Poised for Positive Start
Indian stock market benchmarks Sensex and Nifty 50 are set to extend gains for a third consecutive session on Tuesday, December 23, following positive global trends. Analysts advise a buy-on-dips strategy with key support and resistance levels identified.
Indian Stock Market Snaps 4-Day Losing Streak, Gains 0.5%
Indian stock markets rebounded on Friday, Dec 19, with Sensex gaining 448 pts. Expert Sumeet Bagadia shares Nifty outlook and 3 stock picks for Monday. Read for key triggers.
Bitcoin Braces for $23B Options Expiry, High Volatility
Bitcoin's price faces intense pressure as $23 billion in options contracts expire next Friday, threatening to spike volatility. Traders brace for downside risk amid a fragile market. Read the full analysis.
Page 1 of 4